Beta: Sign in
Shares outstandingAs of 2026-07-31 · filed common shares: 319.35M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 1.63%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 3.31%
Short ratioDays to cover, as published by FINRA: 7.41
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 50.20%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 57.20%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Loading evidence for AMRX

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross marginTTM to Jun 26: 39.32%
Operating marginTTM to Jun 26: 14.56%
Net margin: —
EBITDA marginFY Dec 25: 20.61%
Return on equity: —
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: 4.37%

Growth

Revenue growth (annual YoY): 8.05%
Revenue growth (latest qtr YoY): 9.89%
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): 157.22%
EPS growth (fwd): Sign in
Net income growth (QoQ): -7.38%

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales: Sign in
Price / operating cash flow: Sign in
P/FCF: Sign in
EV / revenue: Sign in
EV / EBITDA: Sign in
EPSDiluted, TTM to Jun 26: 0.48
EPS (fwd): Sign in

Financial health

Cash & equivalentsas of Jun 26: $127.63M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $2.57B
Debt / equityas of Jun 26: 7783.12%
Current ratioas of Jun 26: 2.20
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Dec 22: 1.02
Operating cash flowTTM to Jun 26: $200.77M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: $127.83M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 9.52

AMRX stock Statistics — Amneal Pharmaceuticals, Inc. filings, insiders & smart money · Instaport